• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于人工智能的病理学预测癌症未知原发灶的起源。

AI-based pathology predicts origins for cancers of unknown primary.

机构信息

Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Cancer Program, Broad Institute of Harvard and MIT, Cambridge, MA, USA.

出版信息

Nature. 2021 Jun;594(7861):106-110. doi: 10.1038/s41586-021-03512-4. Epub 2021 May 5.

DOI:10.1038/s41586-021-03512-4
PMID:33953404
Abstract

Cancer of unknown primary (CUP) origin is an enigmatic group of diagnoses in which the primary anatomical site of tumour origin cannot be determined. This poses a considerable challenge, as modern therapeutics are predominantly specific to the primary tumour. Recent research has focused on using genomics and transcriptomics to identify the origin of a tumour. However, genomic testing is not always performed and lacks clinical penetration in low-resource settings. Here, to overcome these challenges, we present a deep-learning-based algorithm-Tumour Origin Assessment via Deep Learning (TOAD)-that can provide a differential diagnosis for the origin of the primary tumour using routinely acquired histology slides. We used whole-slide images of tumours with known primary origins to train a model that simultaneously identifies the tumour as primary or metastatic and predicts its site of origin. On our held-out test set of tumours with known primary origins, the model achieved a top-1 accuracy of 0.83 and a top-3 accuracy of 0.96, whereas on our external test set it achieved top-1 and top-3 accuracies of 0.80 and 0.93, respectively. We further curated a dataset of 317 cases of CUP for which a differential diagnosis was assigned. Our model predictions resulted in concordance for 61% of cases and a top-3 agreement of 82%. TOAD can be used as an assistive tool to assign a differential diagnosis to complicated cases of metastatic tumours and CUPs and could be used in conjunction with or in lieu of ancillary tests and extensive diagnostic work-ups to reduce the occurrence of CUP.

摘要

原发灶不明癌症(CUP)是一组具有挑战性的诊断,其中肿瘤原发部位无法确定。这是一个很大的挑战,因为现代治疗方法主要针对原发肿瘤。最近的研究集中在使用基因组学和转录组学来确定肿瘤的起源。然而,基因组检测并非总是进行,并且在资源有限的环境中缺乏临床渗透。在这里,为了克服这些挑战,我们提出了一种基于深度学习的算法——通过深度学习评估肿瘤起源(TOAD)——该算法可以使用常规获取的组织学幻灯片提供原发肿瘤起源的鉴别诊断。我们使用具有已知原发起源的肿瘤全切片图像来训练一个模型,该模型可以同时识别肿瘤是原发还是转移,并预测其起源部位。在我们的已知原发起源肿瘤验证集上,该模型的 top-1 准确率为 0.83,top-3 准确率为 0.96,而在我们的外部验证集上,它的 top-1 和 top-3 准确率分别为 0.80 和 0.93。我们进一步整理了一个包含 317 例 CUP 病例的数据集,对这些病例进行了鉴别诊断。我们的模型预测结果与 61%的病例一致,top-3 一致率为 82%。TOAD 可以用作辅助工具,对复杂的转移性肿瘤和 CUP 病例进行鉴别诊断,也可以与辅助检查和广泛的诊断性检查结合使用或替代这些检查,以减少 CUP 的发生。

相似文献

1
AI-based pathology predicts origins for cancers of unknown primary.基于人工智能的病理学预测癌症未知原发灶的起源。
Nature. 2021 Jun;594(7861):106-110. doi: 10.1038/s41586-021-03512-4. Epub 2021 May 5.
2
CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence.CUP-AI-Dx:一种使用 RNA 基因表达数据和人工智能推断癌症组织来源和分子亚型的工具。
EBioMedicine. 2020 Nov;61:103030. doi: 10.1016/j.ebiom.2020.103030. Epub 2020 Oct 9.
3
A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary.比较 DNA 测序和基因表达谱分析以辅助不明原发癌的组织起源诊断。
J Pathol. 2023 Jan;259(1):81-92. doi: 10.1002/path.6022. Epub 2022 Nov 30.
4
Prediction of tumor origin in cancers of unknown primary origin with cytology-based deep learning.基于细胞学的深度学习预测不明原发灶癌症的肿瘤起源。
Nat Med. 2024 May;30(5):1309-1319. doi: 10.1038/s41591-024-02915-w. Epub 2024 Apr 16.
5
The practical utility of AI-assisted molecular profiling in the diagnosis and management of cancer of unknown primary: an updated review.人工智能辅助分子谱分析在不明原发癌的诊断和治疗中的实际应用:最新综述。
Virchows Arch. 2024 Feb;484(2):369-375. doi: 10.1007/s00428-023-03708-1. Epub 2023 Nov 24.
6
Cancers of unknown primary origin (CUP) are characterized by chromosomal instability (CIN) compared to metastasis of know origin.与已知原发灶的转移瘤相比,原发灶不明的癌症(CUP)具有染色体不稳定(CIN)的特征。
BMC Cancer. 2015 Mar 19;15:151. doi: 10.1186/s12885-015-1128-x.
7
Development and validation of a gene expression tumour classifier for cancer of unknown primary.一种用于原发性不明癌症的基因表达肿瘤分类器的开发与验证
Pathology. 2015 Jan;47(1):7-12. doi: 10.1097/PAT.0000000000000194.
8
Image-based deep learning model using DNA methylation data predicts the origin of cancer of unknown primary.基于图像的深度学习模型使用 DNA 甲基化数据预测未知原发性癌症的起源。
Neoplasia. 2024 Sep;55:101021. doi: 10.1016/j.neo.2024.101021. Epub 2024 Jun 28.
9
An integrated tool for determining the primary origin site of metastatic tumours.一种用于确定转移性肿瘤原发部位的综合工具。
J Clin Pathol. 2018 Jul;71(7):584-593. doi: 10.1136/jclinpath-2017-204887. Epub 2017 Dec 16.
10
Diagnostic work-up of carcinoma of unknown primary: from immunohistochemistry to molecular profiling.不明原发癌的诊断工作:从免疫组织化学到分子分析。
Ann Oncol. 2012 Sep;23 Suppl 10:x271-7. doi: 10.1093/annonc/mds357.

引用本文的文献

1
Polymerase-based DNA reactions for molecularly computing cancerous diagnostic valences of multiple miRNAs.基于聚合酶的DNA反应用于分子计算多种微小RNA的癌症诊断效价。
J Nanobiotechnology. 2025 Sep 1;23(1):598. doi: 10.1186/s12951-025-03643-0.
2
Intraoperative change in distal motor latency as a predictor for clinical outcome after mini-OCTR: a retrospective cohort study.微型开放性腕管减压术中远端运动潜伏期的术中变化作为临床结局的预测指标:一项回顾性队列研究
Front Neurol. 2025 Aug 13;16:1607199. doi: 10.3389/fneur.2025.1607199. eCollection 2025.
3
Artificial Intelligence-Based Multimodal Prediction of Postoperative Adjuvant Immunotherapy Benefit in Urothelial Carcinoma: Results From the Phase III, Multicenter, Randomized, IMvigor010 Trial.
基于人工智能的尿路上皮癌术后辅助免疫治疗获益的多模态预测:III期、多中心、随机、IMvigor010试验的结果
MedComm (2020). 2025 Aug 25;6(9):e70324. doi: 10.1002/mco2.70324. eCollection 2025 Sep.
4
HistoChat: Instruction-tuning multimodal vision language assistant for colorectal histopathology on limited data.HistoChat:用于有限数据上的结直肠癌组织病理学的指令微调多模态视觉语言助手。
Patterns (N Y). 2025 May 30;6(8):101284. doi: 10.1016/j.patter.2025.101284. eCollection 2025 Aug 8.
5
Advances in nanotechnology-enabled adjuvants for peptide-based cancer vaccines.基于肽的癌症疫苗的纳米技术辅助剂研究进展。
Nano Res. 2025 Jul;18(7). doi: 10.26599/nr.2025.94907534. Epub 2025 May 22.
6
Evolution and integration of artificial intelligence across the cancer continuum in women: advances in risk assessment, prevention, and early detection.人工智能在女性癌症全程中的发展与整合:风险评估、预防及早期检测的进展
Cancer Causes Control. 2025 Aug 20. doi: 10.1007/s10552-025-02048-6.
7
The value of dual-energy spectral CT in differentiating the pathological grades of T1-size lung adenocarcinoma.双能量谱CT在鉴别T1期肺腺癌病理分级中的价值。
J Thorac Dis. 2025 Jul 31;17(7):4858-4871. doi: 10.21037/jtd-2025-516. Epub 2025 Jul 27.
8
Rethinking cancer of unknown primary: from diagnostic challenge to targeted treatment.重新审视原发灶不明的癌症:从诊断挑战到靶向治疗
Nat Rev Clin Oncol. 2025 Aug 4. doi: 10.1038/s41571-025-01060-8.
9
Artificial intelligence and machine learning in the development of vaccines and immunotherapeutics-yesterday, today, and tomorrow.人工智能与机器学习在疫苗和免疫疗法研发中的应用——过去、现在与未来
Front Artif Intell. 2025 Jul 18;8:1620572. doi: 10.3389/frai.2025.1620572. eCollection 2025.
10
Machine learning approaches for EGFR mutation status prediction in NSCLC: an updated systematic review.用于非小细胞肺癌中表皮生长因子受体突变状态预测的机器学习方法:一项更新的系统评价
Front Oncol. 2025 Jul 10;15:1576461. doi: 10.3389/fonc.2025.1576461. eCollection 2025.